Slideshow

Antipsychotics-To Respond or Not to Respond?

Author(s):

Brian Miller, MD, PhD, MPH

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
digital brain
January 17th 2025

Breaking Down Barriers to Quality Care for Patients With Schizophrenia

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
antipsychotics
January 14th 2025

Discontinuing Antipsychotics

Joshua Feder, MD, DFAPA Charmi Patel Rao, MD, DFAACAP
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
How ‘Real’ Are Psychiatric Disorders? AI Has Its Say
December 27th 2024

How ‘Real’ Are Psychiatric Disorders? AI Has Its Say

Ronald W. Pies, MD
FDA
December 23rd 2024

A Conversation About the Clozapine REMS

Michael Asbach, DMSc, PA-C, Psych-CAQ Autumn Roque, DNP, APRN, PMHNP-BC
© 2025 MJH Life Sciences

All rights reserved.